Regulus Therapeutics
RGLS
#8838
Rank
HK$0.86 B
Marketcap
HK$13.10
Share price
-6.39%
Change (1 day)
-33.61%
Change (1 year)

Regulus Therapeutics (RGLS) - Cash on Hand

Cash on Hand as of December 2024 : HK$0.58 Billion

According to Regulus Therapeutics's latest financial reports the company has HK$0.58 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Regulus Therapeutics - Cash on Hand chart (from 2011 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$0.58 B216.93%
2023-12-31HK$0.18 B-39.33%
2022-12-31HK$0.30 B-35.02%
2021-12-31HK$0.47 B95.38%
2020-12-31HK$0.24 B-9.31%
2019-12-31HK$0.26 B143.52%
2018-12-31HK$0.10 B-76.75%
2017-12-31HK$0.46 B-20.48%
2016-12-31HK$0.59 B-33.24%
2015-12-31HK$0.88 B-28.65%
2014-12-31HK$1.23 B40.16%
2013-12-31HK$0.88 B16.26%
2012-12-31HK$0.76 B156.66%
2011-12-31HK$0.29 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$36.23 B 6,050.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$64.12 B 10,785.84%๐Ÿ‡ซ๐Ÿ‡ท France
HK$18.46 B 3,034.20%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$43.95 B 7,361.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$20.94 B 3,455.83%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.32 B-44.68%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$84.41 B 14,230.21%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA